These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
694 related articles for article (PubMed ID: 9855156)
1. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine. Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty. Ren J; Shin DH; Chung HS; Birt CM; Glover BK; Juzych MS; Hughes BA; Kim C Ophthalmology; 1999 Jun; 106(6):1135-9. PubMed ID: 10366082 [TBL] [Abstract][Full Text] [Related]
3. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy. Yuen NS; Cheung P; Hui SP Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723 [TBL] [Abstract][Full Text] [Related]
4. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures. Chevrier RL; Assalian A; Duperré J; Lesk MR Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. Lam DS; Leung DY; Tham CC; Li FC; Kwong YY; Chiu TY; Fan DS Ophthalmology; 2008 Jul; 115(7):1134-40. PubMed ID: 18164064 [TBL] [Abstract][Full Text] [Related]
6. Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy. Kitazawa Y; Taniguchi T; Sugiyama K Ophthalmic Surg; 1989 Jan; 20(1):49-52. PubMed ID: 2648232 [TBL] [Abstract][Full Text] [Related]
7. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%. Barnes SD; Campagna JA; Dirks MS; Doe EA Ophthalmology; 1999 Oct; 106(10):2033-7. PubMed ID: 10519604 [TBL] [Abstract][Full Text] [Related]
8. The combined use of apraclonidine and pilocarpine during laser iridotomy in a Hispanic population. Fernandez-Bahamonde JL; Alcaraz-Michelli V Ann Ophthalmol; 1990 Dec; 22(12):446-9. PubMed ID: 2078039 [TBL] [Abstract][Full Text] [Related]
9. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma. Nishimoto JH; Chang FW; Tang IH; Kolin T J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699 [TBL] [Abstract][Full Text] [Related]
10. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group. Robin AL; Ritch R; Shin D; Smythe B; Mundorf T; Lehmann RP Trans Am Ophthalmol Soc; 1995; 93():421-38; discussion 439-41. PubMed ID: 8719690 [TBL] [Abstract][Full Text] [Related]
11. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise. Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768 [TBL] [Abstract][Full Text] [Related]
12. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy. Unal M; Yücel I; Akar Y J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262 [TBL] [Abstract][Full Text] [Related]